Clinical Trials Update: May 19, 2005
Leukemia (Pediatric) Diabetes Mellitus Types 1 and 2 Lung Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
The goals of this research study are to test the safety of depsipeptide; to see what effects (good and bad) it has on children and children's cancer; and to find the highest dose of depsipeptide that can be given to children without causing severe side effects.
Patients who are under 22 years of age with solid tumors, either extracranial solid tumors or brain tumors, are eligible to participate in this clinical trial.
The research site is in Cincinnati, Ohio.
Diabetes Mellitus Types 1 and 2
Men and women, age 18 and over, with type 2 diabetes mellitus may be eligible to participate in a research study to test an investigational medication.
Qualified participants may receive at no cost a study-related physical exam, study-related medication, medication to treat high blood pressure, and study-related laboratory tests.
Research site is in Concord, Calif.
The goals of this study are to determine the safety of administering Onconase intravenously on days 1 and 4 of each of three consecutive weeks with the treatment cycle repeated every 28 days and to determine any side effects that might be associated with the regimen; to find out whether Onconase can make the tumor smaller or disappear, and for how long.
Qualified participants must be adults with Stage 3b or 4 non-small cell lung cancer (NSCLC).
The research site is in Grand Rapids, Mich.
Copyright 2005 CenterWatch. All rights reserved.